Skip to main content

Table 3 Comparison of baseline medication between patients who died and who were alive at 1 year

From: Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry

MedicationsDied at 1 year
(n = 39)
n (%)
Alive at 1 year
(n = 357)
n (%)
p-value
Antiplatelet37 (94.9%)350 (98.0%)0.219
 Aspirin34 (91.9%)332 (94.9%)0.439
 Clopidogrel13 (35.1%)143 (40.9%)0.500
 Ticagrelor2 (5.4%)7 (2.0%)0.209
 Warfarin9 (24.3%)58 (16.6%)0.236
Beta-blocker29 (74.4%)273 (76.5%)0.769
 Bisoprolol1 (3.4%)34 (12.5%)0.223
 Metoprolol succinate0 (0.0%)6 (2.2%)1.000
 Metoprolol tartrate5 (17.2%)24 (8.8%)0.176
 Carvedilol20 (69.0%)197 (72.2%)0.716
 Nebivolol0 (0.0%)0 (0.0%)
 Atenolol1 (3.4%)10 (3.7%)1.000
 Propranolol2 (6.9%)2 (0.7%)0.047
Non-guideline-recommended8 (27.6%)36 (13.2%)0.050
beta-blocker (metoprolol tartrate or atenolol or propanolol)
ACE inhibitors16 (41.0%)154 (43.1%)0.800
ARB11 (28.2%)99 (27.7%)0.950
Nitrates12 (30.8%)116 (32.5%)0.827
Hydralazine3 (7.7%)34 (9.5%)1.000
Trimetazidine3 (7.7%)26 (7.3%)1.000
Ivabradine3 (7.7%)8 (2.2%)0.084
Diuretics30 (76.9%)255 (71.4%)0.468
Digitalis7 (17.9%)42(11.8%)0.302
Statins36 (94.7%)333 (99.7%)0.029
Insulin8 (57.1%)47 (41.2%)0.256
Sulfonylureas4 (28.6%)57 (50.0%)0.130
Biguanides6 (42.9%)52 (45.6%)0.845
Thiazolidinediones0 (0.0%)3 (2.6%)1.000
  1. A p-value< 0.05 indicates statistical significance
  2. Abbreviations: ACEI angiotensin-converting enzyme inhibitors; ARB angiotensin receptor blockers